Schedule 3 Drugs clinical reference logo

U.S. federal terminology reference

Schedule 3 Drugs

In U.S. law and DEA materials, the official term is Schedule III controlled substances. This page explains the search phrase schedule 3 drugs using federal source language, plain-English framing, and dated citations.

Last reviewed: April 24, 2026 Informational summary only. This page does not provide medical, prescribing, or legal advice.

Official definition

What the federal standard is actually testing for.

01

Accepted medical use

The federal standard treats Schedule III substances as drugs or other substances with currently accepted medical use in treatment in the United States.

02

Lower abuse potential than Schedule I or II

The classification sits below Schedules I and II on abuse potential, but above Schedules IV and V in the federal scheduling ladder.

03

Dependence can still be significant

Federal law does not treat Schedule III as low-risk or casual. Abuse may still lead to moderate or low physical dependence or high psychological dependence.

Classification criteria

The three checks behind a Schedule III designation.

A

Medical use is established

The substance is not placed in Schedule I if it has currently accepted medical use in treatment in the United States.

B

Abuse potential is comparatively lower

Federal law positions Schedule III below Schedules I and II for abuse potential, which is why the comparison matters.

C

Dependence risk is still real

The schedule still recognizes meaningful dependence risk. It is not a synonym for safe, unrestricted, or non-controlled.

Examples with caution

Illustrative examples the DEA names in its public scheduling summary.

These are examples, not a complete legal list. Formulation, dosage unit, later rulemaking, and federal updates can change how a substance is scheduled.

DEA example

Codeine combination products

DEA lists products containing less than 90 milligrams of codeine per dosage unit as a Schedule III example.

DEA example

Ketamine

Ketamine appears in the DEA public summary as a Schedule III example. Verify current regulatory context before relying on a summary page.

DEA example

Anabolic steroids

Anabolic steroids are also listed in the DEA overview and remain part of the common public understanding of Schedule III examples.

DEA example

Testosterone

Testosterone is another example named by the DEA. The example is illustrative and should always be checked against the current official source.

FAQ

Questions that usually sit behind the keyword.

Official sources

Primary sources used for this page.

Each link below points to a primary U.S. government source reviewed on April 24, 2026.